Potential for synthesis and degradation of extracellular matrix proteins by valve interstitial cells seeded onto collagen scaffolds.
暂无分享,去创建一个
M. Yacoub | E. Sachlos | J. Czernuszka | A. Chester | S. Dreger | P. Thomas | P. Taylor
[1] V. Joag,et al. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. , 2007, The American journal of pathology.
[2] Eleftherios Sachlos,et al. Interaction of human valve interstitial cells with collagen matrices manufactured using rapid prototyping. , 2006, Biomaterials.
[3] M. Yacoub,et al. Extracellular matrix scaffolds for tissue engineering heart valves , 2006 .
[4] J. Takkenberg,et al. Will heart valve tissue engineering change the world? , 2005, Nature Clinical Practice Cardiovascular Medicine.
[5] Frederick J Schoen,et al. Heart valve regeneration. , 2005, Advances in biochemical engineering/biotechnology.
[6] M. Yacoub,et al. Regulation of ecto-5′-nucleotidase by TNF-α in human endothelial cells , 2002, Molecular and Cellular Biochemistry.
[7] S. Curran,et al. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression , 2003, The Journal of pathology.
[8] Ivan Stamenkovic,et al. Extracellular matrix remodelling: the role of matrix metalloproteinases , 2003, The Journal of pathology.
[9] Ivan Stamenkovic,et al. Functional structure and composition of the extracellular matrix , 2003, The Journal of pathology.
[10] B Derby,et al. Novel collagen scaffolds with predefined internal morphology made by solid freeform fabrication. , 2003, Biomaterials.
[11] R. Tarnuzzer,et al. Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro. , 2003, Investigative ophthalmology & visual science.
[12] M. Kuzuya,et al. Role of matrix metalloproteinases in vascular remodeling. , 2003, Journal of atherosclerosis and thrombosis.
[13] Magdi H Yacoub,et al. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. , 2002, The Journal of heart valve disease.
[14] Simon P. Hoerstrup,et al. Tissue Engineering of Functional Trileaflet Heart Valves From Human Marrow Stromal Cells , 2002, Circulation.
[15] Magdi H Yacoub,et al. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. , 2002, The Journal of heart valve disease.
[16] G. Fields,et al. Matrix metalloproteinases and collagen catabolism. , 2002, Biopolymers.
[17] L. Matrisian,et al. Matrix metalloproteinases: they're not just for matrix anymore! , 2001, Current opinion in cell biology.
[18] B Glasmacher,et al. In vitro modelling of tissue using isolated vascular cells on a synthetic collagen matrix as a substitute for heart valves. , 2001, The Thoracic and cardiovascular surgeon.
[19] W. Stetler-Stevenson,et al. Proteases in invasion: matrix metalloproteinases. , 2001, Seminars in cancer biology.
[20] H. Alexander,et al. Development and characterization of tissue-engineered aortic valves. , 2001, Tissue engineering.
[21] Antoon F. M. Moorman,et al. Sensitive Nonradioactive Detection of mRNA in Tissue Sections: Novel Application of the Whole-mount In Situ Hybridization Protocol , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[22] S. Hoerstrup,et al. Optimized Growth Conditions for Tissue Engineering of Human Cardiovascular Structures , 2000, The International journal of artificial organs.
[23] F J Schoen,et al. Functional Living Trileaflet Heart Valves Grown In Vitro , 2000, Circulation.
[24] A Haverich,et al. Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits: In Vivo Restoration of Valve Tissue , 2000, Circulation.
[25] F J Schoen,et al. Tissue engineering of heart valves: in vitro experiences. , 2000, The Annals of thoracic surgery.
[26] F J Schoen,et al. Tissue-engineered valved conduits in the pulmonary circulation. , 2000, The Journal of thoracic and cardiovascular surgery.
[27] J. Woessner,et al. Matrix metalloproteinases and TIMPs , 2000 .
[28] M. Yacoub,et al. Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. , 2000, The Journal of heart valve disease.
[29] A. Khaghani,et al. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy , 1999, European journal of clinical investigation.
[30] M. Yacoub,et al. Ecto-5'-nucleotidase activity is reduced in the presence of TNF-alpha in human endothelial cells , 1999 .
[31] A Haverich,et al. Tissue engineering of heart valves--human endothelial cell seeding of detergent acellularized porcine valves. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[32] R Langer,et al. Tissue-engineered heart valve leaflets: does cell origin affect outcome? , 1997, Circulation.
[33] C K Breuer,et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. , 1995, The Annals of thoracic surgery.
[34] J. McEwan,et al. Matrix metalloproteinases and cardiovascular disease. , 1995, Circulation research.
[35] M. Simionescu,et al. Interstitial Cells of the Heart Valves Possess Characteristics Similar to Smooth Muscle Cells , 1986, Circulation research.